医学
家庭医学
类风湿性关节炎
德尔菲法
银屑病性关节炎
利益相关方参与
利益相关者
流感疫苗
免疫学
接种疫苗
公共关系
政治学
数学
统计
作者
Shilpa Venkatachalam,Kelly Gavigan,Laura Stradford,Vandana Dronadula,Angela Degrassi,W. Benjamin Nowell,Shubhasree Banerjee,Peter A. Merkel,Michael George,Jennifer Gordon,Dianne G Shaw,Kalen Larsen,Lisa Emrich,Robert N. McBurney,Hope Sullivan,Ashira Blazer,Brittany Banbury,Kimberly N. Weaver,Michael Kappelman,Jeffrey R. Curtis
摘要
Objective The study objective was to prioritize topics for future patient‐centered research to increase uptake of common vaccines, such as for pneumococcal pneumonia, influenza, herpes zoster, human papillomavirus, and severe acute respiratory syndrome coronavirus 2, among adults living with autoimmune conditions. Methods A steering committee (SC) was formed that included clinicians, patients, patient advocates, and researchers associated with rheumatic diseases (psoriatic arthritis, rheumatoid arthritis, vasculitis), inflammatory bowel disease, and multiple sclerosis. Through a scoping review and discussions, SC members identified research topics regarding vaccine uptake and/or hesitancy for prioritization. A larger multistakeholder alliance that included patients and patient advocates, clinicians, researchers, policy makers, regulators, and vaccine manufacturers conducted a modified Delphi exercise online with three rating rounds and one ranking round. Frequency analysis and comparisons across stakeholder groups were conducted. A weighted ranking score was generated for each item in the ranking round for final prioritization. Results Through the Delphi process, 33 research topics were identified, of which 13 topics were rated as critical by more than 70% of all stakeholders (n = 31). The two highest ranked critical topics per the full stakeholder group were “How well a vaccine works for adults with autoimmune conditions” and “How beliefs about vaccine safety affect vaccine uptake.” Conclusion A multistakeholder group identified key topics as critically important priorities for future research to decrease vaccine hesitancy and improve uptake of vaccines for adults with autoimmune conditions.
科研通智能强力驱动
Strongly Powered by AbleSci AI